Low-cost personal DNA readings are on the way
By Peter Aldhous,
New Scientist
| 09. 06. 2007
"GENETICS is about to get personal." So proclaims the website of 23andMe, a Californian company that is gearing up to offer people a guided tour of their own DNA. For the superstars of genetics, it has already got personal. Earlier this week, genomics pioneer Craig Venter revealed an almost complete sequence of his genome, while that of James Watson, co-discoverer of DNA's double-helix structure, has been available on the web since late June.
Given that Watson's genome took almost $1 million to read, most of us won't immediately be following in his and Venter's footsteps. It isn't necessary to read your entire genome, however, to browse many of the genetic variations that may influence your health. According to George Church, a geneticist at Harvard Medical School in Boston, the most pertinent information could be gleaned by sequencing the 1 per cent of the genome that codes for proteins. Thanks to the advances in sequencing technology, that might be done for as little as $1000 per person. "DNA chips", meanwhile, can scan your genome for common "spelling mistakes" for...
Related Articles
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...
By Hannah Devlin, The Guardian | 12.06.2025
Couples undergoing IVF in the UK are exploiting an apparent legal loophole to rank their embryos based on genetic predictions of IQ, height and health, the Guardian has learned.
The controversial screening technique, which scores embryos based on their DNA...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...
By Vardit Ravitsky, The Hastings Center | 12.04.2025
Embryo testing is advancing fast—but how far is too far? How and where do we draw the line between preventing disease and selecting for “desirable” traits? What are the ethical implications for parents, children, clinicians, and society at large? These...
